"3"^^ . "Chronic B-lymphatic leukemia (B-CLL) is a low aggressive (malign) lymphoproliferative disease developing due to proliferation of clonal, malignantly transformed mature B-lymphocytes (1,2,9,16).This type of leukemia is the most frequent leukemia in adults in Europe and North America (30-40 % of all leukemias)(13). Its incidence in Europe is 3/100 000, twice more frequent in males than in females, and usually at over 50 years of age (1, 2, 9, 13). Lymphotropic viri inhibiting the apoptosis in the attacked B-cell presumably assert in the etiology. The role of Epstein-Barr\u2019s virus and bovine herpes virus (BHV-4) that induce the production of antiapoptic protein Bcl-2 in B-cells is discussed. Even the adenoviri (E\u00B41B55kDA) and papilloviri inhibiting the antiapoptic protein Bcl-2 are considered. The influence of radiation or chemical substances has not been proven in the etiopathology of B-CLL (13)."@en . . "Kryptokok\u00F3za u nemocn\u00E9ho s progreduj\u00EDc\u00ED chronickou B-lymfatickou leuk\u00E9mi\u00ED"@cs . . . "Kryptokok\u00F3za u nemocn\u00E9ho s progreduj\u00EDc\u00ED chronickou B-lymfatickou leuk\u00E9mi\u00ED" . "S, Z(MO0FVZ0000503)" . . . "Cryptoccoccosis; patient; progressive; chronic; B-lymphatic; leukemia"@en . . . . . "10"^^ . . "Ka\u0161parov\u00E1 (Bene\u0161ov\u00E1), Petra" . . "8" . "Chronick\u00E1 B-lymfatick\u00E1 leuk\u00E9mie (B-CLL) je n\u00EDzce agresivn\u00ED (malign\u00ED) lymfoproliferativn\u00ED onemocn\u011Bn\u00ED vznikaj\u00EDc\u00ED na podklad\u011B proliferace klon\u00E1ln\u00EDch, malign\u011B transformovan\u00FDch vyzr\u00E1l\u00FDch B lymfocyt\u016F (1, 2, 9, 16). Tento typ leuk\u00E9mie je nej\u010Dast\u011Bj\u0161\u00ED leuk\u00E9mi\u00ED dosp\u011Bl\u00FDch v Evrop\u011B a Severn\u00ED Americe, (30\u201340 % v\u0161ech leuk\u00E9mi\u00ED) (13). Jej\u00ED incidence v Evrop\u011B je 3/100 000, 2* \u010Dast\u011Bji se vyskytuje u mu\u017E\u016F v porovn\u00E1n\u00ED se \u017Eenami a zpravidla se vyskytuje u osob star\u0161\u00EDch 50 rok\u016F (1, 2, 9, 13). V etiologii B-CLL se pravd\u011Bpodobn\u011B uplat\u0148uj\u00ED lymfotropn\u00ED viry inhibuj\u00EDc\u00ED apopt\u00F3zu v napaden\u00E9 B bu\u0148ce. Diskutuje se i o \u00FAloze Epstein-Barrov\u00E9 viru a bovinn\u00EDho herpes viru (BHV- 4), kter\u00E9 indukuj\u00ED v B bu\u0148k\u00E1ch produkci antiapoptick\u00E9ho proteinu Bcl-2. V \u00FAvahu p\u0159ipadaj\u00ED i adenoviry (E=1B55kDA) a papilomaviry inhibuj\u00EDc\u00ED antiapoptick\u00FD gen p53 (11, 13). Vliv z\u00E1\u0159en\u00ED \u010Di chemick\u00FDch l\u00E1tek v etiopatogenezi B-CLL nebyl prok\u00E1z\u00E1n (13)."@cs . . "[3455EEC6D75C]" . "135;137" . "CZ - \u010Cesk\u00E1 republika" . "Kryptokok\u00F3za u nemocn\u00E9ho s progreduj\u00EDc\u00ED chronickou B-lymfatickou leuk\u00E9mi\u00ED"@cs . "Kryptokok\u00F3za u nemocn\u00E9ho s progreduj\u00EDc\u00ED chronickou B-lymfatickou leuk\u00E9mi\u00ED" . . "11150" . "Slov\u00E1\u010Dkov\u00E1, Birgita" . "Cryptoccoccosis in a patient with progressive chronic B-lymphatic leukemia"@en . "RIV/00216208:11150/06:00005010!RIV08-MSM-11150___" . "1212-7299" . . "Intern\u00ED medic\u00EDna pro praxi (p\u0159\u00EDl. Mezioborov\u00E9 p\u0159ehledy)" . "RIV/00216208:11150/06:00005010" . . . . "\u017D\u00E1k, Pavel" . "482559" . . "Cryptoccoccosis in a patient with progressive chronic B-lymphatic leukemia"@en . . "Bla\u017Eek, Martin" . . "Chronick\u00E1 B-lymfatick\u00E1 leuk\u00E9mie (B-CLL) je n\u00EDzce agresivn\u00ED (malign\u00ED) lymfoproliferativn\u00ED onemocn\u011Bn\u00ED vznikaj\u00EDc\u00ED na podklad\u011B proliferace klon\u00E1ln\u00EDch, malign\u011B transformovan\u00FDch vyzr\u00E1l\u00FDch B lymfocyt\u016F (1, 2, 9, 16). Tento typ leuk\u00E9mie je nej\u010Dast\u011Bj\u0161\u00ED leuk\u00E9mi\u00ED dosp\u011Bl\u00FDch v Evrop\u011B a Severn\u00ED Americe, (30\u201340 % v\u0161ech leuk\u00E9mi\u00ED) (13). Jej\u00ED incidence v Evrop\u011B je 3/100 000, 2* \u010Dast\u011Bji se vyskytuje u mu\u017E\u016F v porovn\u00E1n\u00ED se \u017Eenami a zpravidla se vyskytuje u osob star\u0161\u00EDch 50 rok\u016F (1, 2, 9, 13). V etiologii B-CLL se pravd\u011Bpodobn\u011B uplat\u0148uj\u00ED lymfotropn\u00ED viry inhibuj\u00EDc\u00ED apopt\u00F3zu v napaden\u00E9 B bu\u0148ce. Diskutuje se i o \u00FAloze Epstein-Barrov\u00E9 viru a bovinn\u00EDho herpes viru (BHV- 4), kter\u00E9 indukuj\u00ED v B bu\u0148k\u00E1ch produkci antiapoptick\u00E9ho proteinu Bcl-2. V \u00FAvahu p\u0159ipadaj\u00ED i adenoviry (E=1B55kDA) a papilomaviry inhibuj\u00EDc\u00ED antiapoptick\u00FD gen p53 (11, 13). Vliv z\u00E1\u0159en\u00ED \u010Di chemick\u00FDch l\u00E1tek v etiopatogenezi B-CLL nebyl prok\u00E1z\u00E1n (13)." . "4"^^ . "3" . . .